日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study

口服补充左旋胱氨酸、锯棕榈、南瓜和非洲臀果木治疗慢性休止期脱发和雄激素性脱发：一项双盲、安慰剂对照、随机临床研究

期刊:Skin Appendage Disorders
影响因子:1.3
doi:10.1159/000540081
Piquero-Casals, Jaime; Saceda-Corralo, David; Aladren, Sonia; Bustos, Javier; Fernández-Botello, Alfonso; Navasa, Albert; Logusso, Georgina; Jourdan, Eric; Mir-Bonafé, Juan Francisco; Morgado-Carrasco, Daniel
免疫/内分泌
发表日期：2025
文献求助 收藏

Prospective Evaluation of the Efficacy of a Food Supplement in Increasing Photoprotection and Improving Selective Markers Related to Skin Photo-Ageing

前瞻性评估一种食品补充剂在增强光保护和改善与皮肤光老化相关的特定标志物方面的功效

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-019-00345-y
Granger, Corinne; Aladren, Sonia; Delgado, Jesus; Garre, Aurora; Trullas, Carles; Gilaberte, Yolanda
衰老
发表日期：2020
文献求助 收藏

Night Cream Containing Melatonin, Carnosine and Helichrysum italicum Extract Helps Reduce Skin Reactivity and Signs of Photodamage: Ex Vivo and Clinical Studies

含有褪黑激素、肌肽和蜡菊提取物的晚霜有助于减少皮肤反应和光损伤迹象：体外和临床研究

期刊:Dermatologic Therapy
影响因子:
doi:10.1007/s13555-020-00443-2
Corinne Granger, Anthony Brown, Sonia Aladren, Mridvika Narda
免疫/内分泌
发表日期：2020
文献求助 收藏

Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors

针对黑色素瘤的 MCL1 偏向释放了 BRAF 和 ERK1/2 通路抑制剂的凋亡潜力

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-019-12409-w
Matthew J Sale, Emma Minihane, Noel R Monks, Rebecca Gilley, Frances M Richards, Kevin P Schifferli, Courtney L Andersen, Emma J Davies, Mario Aladren Vicente, Eiko Ozono, Aleksandra Markovets, Jonathan R Dry, Lisa Drew, Vikki Flemington, Theresa Proia, Duncan I Jodrell, Paul D Smith, Simon J Cook
信号转导
肿瘤
黑色素瘤
IP
WB
Apoptosis
MAPK/ERK
发表日期：2019
文献求助 收藏

Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients

坚持药物治疗和辅助屏障修复疗法是轻度至中度痤疮临床改善的关键因素：一项纳入 643 名患者的 ACTUO 观察性前瞻性多中心队列试验

期刊:BMC Dermatology
影响因子:
doi:10.1186/s12895-015-0036-8
de Lucas, Raúl; Moreno-Arias, Gerardo; Perez-López, Montserrat; Vera-Casaño, Ángel; Aladren, Sonia; Milani, Massimo
发表日期：2015
文献求助 收藏